Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 17.03% is 376% above its 5-year average of -6.16%, near the high end of its 5-year range (-36.16%–18.44%).
32.56% above its 12-month average of 12.85%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 15.29%.
OPERATING MARGIN
17.03%
OPERATING MARGIN AVG TTM
12.85%
OPERATING MARGIN AVG 3Y
6.45%
OPERATING MARGIN AVG 5Y
-6.16%
OPERATING MARGIN AVG 10Y
-15.52%
OPERATING MARGIN AVG 15Y
-38.50%
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+32.56%
CURRENT VS 3Y AVG
+163.97%
CURRENT VS 5Y AVG
+376.29%
CURRENT VS 10Y AVG
+209.76%
CURRENT VS 15Y AVG
+144.23%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$3.56B
Operating Margin
-1.17%
TTM Avg
-12.22%
3Y Avg
-19.38%
5Y Avg
-20.83%
Market Cap
$3.52B
Operating Margin
-178.39%
TTM Avg
-262.24%
3Y Avg
-320.96%
5Y Avg
-353.79%
Market Cap
$3.52B
Operating Margin
-4974.27%
TTM Avg
-2487.14%
3Y Avg
-1585.80%
5Y Avg
-1144.82%
Market Cap
$3.49B
Operating Margin
-72.84%
TTM Avg
-2371.95%
3Y Avg
-1360.37%
5Y Avg
-967.05%
Market Cap
$3.44B
Operating Margin
-21982.57%
TTM Avg
-10991.28%
3Y Avg
-7569.11%
5Y Avg
-5786.72%
Market Cap
$3.39B
Operating Margin
7.59%
TTM Avg
16.94%
3Y Avg
-4.86%
5Y Avg
-19.92%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Veracyte, Inc. (VCYT) | $3.56B | 17.03% | 12.85% | 6.45% | -6.16% |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.56B | -1.17% | -12.22% | -19.38% | -20.83% |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.52B | -178.39% | -262.24% | -320.96% | -353.79% |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.52B | -4974.27% | -2487.14% | -1585.80% | -1144.82% |
| Celcuity Inc. (CELC)vs › | $3.49B | 0.00% | 0.00% | 0.00% | 0.00% |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.49B | -72.84% | -2371.95% | -1360.37% | -967.05% |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.44B | -21982.57% | -10991.28% | -7569.11% | -5786.72% |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.39B | 7.59% | 16.94% | -4.86% | -19.92% |
| CareDx, Inc (CDNA)vs › | $3.38B | -0.92% | 2.81% | -22.73% | -18.78% |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.32B | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
72.1%
Operating Margin
17.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 15.29% |
| 2026-03-31 | 17.15% |
| 2025-12-31 | 18.44% |
| 2025-09-30 | 17.40% |
| 2025-06-30 | -4.05% |
| 2025-03-31 | 2.54% |
| 2024-12-31 | 3.52% |
| 2024-09-30 | 10.37% |
| 2024-06-30 | 4.03% |
| 2024-03-31 | -4.81% |
| 2023-12-31 | -36.16% |
| 2023-09-30 | -35.22% |
| 2023-06-30 | -8.91% |
| 2023-03-31 | -12.74% |
| 2022-12-31 | -6.75% |
| 2022-09-30 | -12.81% |
| 2022-06-30 | -14.73% |
| 2022-03-31 | -22.50% |
| 2021-12-31 | -18.32% |
| 2021-09-30 | -27.63% |
| 2021-06-30 | -13.56% |
| 2021-03-31 | -123.74% |
| 2020-12-31 | -23.37% |
| 2020-09-30 | -13.07% |
| 2020-06-30 | -53.38% |
| 2020-03-31 | -39.20% |
| 2019-12-31 | -27.57% |
| 2019-09-30 | -5.69% |
| 2019-06-30 | -10.29% |
| 2019-03-31 | -7.00% |
| 2018-12-31 | -11.87% |
| 2018-09-30 | -18.34% |
| 2018-06-30 | -26.01% |
| 2018-03-31 | -44.68% |
| 2017-12-31 | -30.84% |
| 2017-09-30 | -36.35% |
| 2017-06-30 | -35.91% |
| 2017-03-31 | -45.75% |
| 2016-12-31 | -20.11% |
| 2016-09-30 | -26.26% |
| 2016-06-30 | -71.51% |
| 2016-03-31 | -71.96% |
| 2015-12-31 | -56.62% |
| 2015-09-30 | -72.06% |
| 2015-06-30 | -76.20% |
| 2015-03-31 | -67.33% |
| 2014-12-31 | -66.06% |
| 2014-09-30 | -79.40% |
| 2014-06-30 | -75.61% |
| 2014-03-31 | -87.95% |
| 2013-12-31 | -84.26% |
| 2013-09-30 | -109.06% |
| 2013-06-30 | -106.89% |
| 2013-03-31 | -134.42% |
| 2012-12-31 | -114.79% |
| 2012-09-30 | -153.19% |